Widely Used Inhalers Won’t Cost More Than $35 a Month, AstraZeneca Says
AstraZeneca, the UK-based maker of popular inhalers like Symbicort and Airsupra, announced Monday it plans to cap costs for patients using its inhalers in the U.S. at $35 per month…